SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001140361-24-003407
Filing Date
2024-01-23
Accepted
2024-01-23 16:05:34
Documents
16
Period of Report
2023-11-13
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A ny20014884x4_8ka.htm   iXBRL 8-K/A 33452
2 EXHIBIT 23.1 ny20014884x4_ex23-1.htm EX-23.1 2311
3 EXHIBIT 99.1 ny20014884x4_ex99-1.htm EX-99.1 364230
4 EXHIBIT 99.2 ny20014884x4_ex99-2.htm EX-99.2 286485
5 EXHIBIT 99.3 ny20014884x4_ex99-3.htm EX-99.3 503232
  Complete submission text file 0001140361-24-003407.txt   1423556

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA selb-20231113.xsd EX-101.SCH 3872
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE selb-20231113_lab.xml EX-101.LAB 22547
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE selb-20231113_pre.xml EX-101.PRE 16049
10 EXTRACTED XBRL INSTANCE DOCUMENT ny20014884x4_8ka_htm.xml XML 4071
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37798 | Film No.: 24552522
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)